The plasma level of any substance represents a balance between its rate of entry into the bloodstream and the rate at which it is metabolized. Adrenocortical steroids are removed rapidly from the circulation so that their plasma levels will reflect their rate of secretion. Unfortunately only cortisol (hydrocortisone) is present in concentrations high enough to be measured routinely by the techniques at present available.
A number of methods have been described for measuring plasma cortisol levels but most of these are too laborious for routine clinical use. The only method which has been widely used is Peterson's modification of the Porter-Silber method for estimating plasma 17-hydroxycorticoids (Peterson et al. 1957 ). This method is not as specific for cortisol as the more complicated methods using chromatographic separation of the plasma steroids, but in normal individuals about 90% of the Porter-Silber chromogens is free cortisol (Peterson et al. 1955) .
We have used this method to study the recovery of adrenal function after prolonged corticosteroid therapy, and have shown that plasma 17-hydroxycorticoid levels return to normal within forty-eight hours of withdrawing corticosteroid therapy in patients with an intact pituitary-adrenal axis (Robinson et al. 1962) . Although this method has proved extremely useful for research purposes it has certain shortcomings which make it less suitable for routine clinical use. It is time consuming; the reagents are rather difficult to prepare; and at least 5 ml of plasma is required for a single estimation.
It has been known for many years that certain steroids will fluoresce in concentrated sulphuric acid and several methods have now been developed for measuring cortisol and corticosterone in plasma using this technique. I have described a simple fluorimetric method for estimating free 11-hydroxycorticoids in human plasma which has many clinical applications and which has been used routinely in the investigation of adrenocortical function for the past two years (Mattingly 1962) . This method measures both cortisol and corticosterone, but only very small amounts of the latter hormone are present in human plasma (Bush & Sandberg 1953) .
Only 2 ml of plasma is used for each estimation, and six estimations can be completed in one and a half hours. None of the synthetic analogues of cortisol or cortisone fluoresces significantly, so that it is possible to measure a patient's adrenocortical activity during their administration.
Over 2,000 plasma 1 l-hydroxycorticoid estimations have been made by this fluorimetric method in order to evaluate its usefulness as a measure of adrenocortical activity. The results of some of these investigations are reported in this paper.
Normal Levels
There is a marked diurnal rhythm of the plasma cortisol level in normal individuals, and it is necessary therefore to pay particular attention to the time of day at which blood is taken when interpreting the results. Peak levels normally occur in the morning and fall gradually during the day to reach their lowest levels at night. The mean plasma 1 1-hydroxycorticoid level between 9 and 10 a.m. in 100 adult hospital patients was 14*7 pg/100 ml, the range being 5-7 to 23-7 jig/ 100 ml (mean ± 2 s.d.). Plasma levels between 9 and 10 a. m. in 12 children, ranging in age from 4 months to 15 years, were all within the adult range. Patients with endocrine, liver or renal disease were excluded and none of these patients was acutely ill at the time or being subjected to stressful procedures. There, was no significant sex or age difference.
The normal diurnal rhythm was studied in 16 adult patients and the meanlevel was 8&3 ,ug/l00ml between 6 and 7 p.m., falling to a mean of 3*3 ,ug/ 100 ml at midnight.
Response to Stress
Stress of any kind may temporarily increase adrenocortical activity and produce elevated plasma 1 1-hydroxycorticoid levels at any time of the day. Levels ranging from 31 to 111 pg/100 ml have been found in 26 patients suffering from acute illnesses or undergoing surgery. The highest level of 111 pg/l00 ml was in a woman of 72 who died shartly afterwards from fulminating bronchopneumonia. She was severely hypotensive for some hours before death. When a patient with suspected Addison's disease has already been started on corticosteroid therapy it is unnecessary to stop it during the test. However, the corticotrophin stimulation must be prolonged for several days in order to overcome the secondary adrenal atrophy due to the treatment. Synthetic corticosteroids must be substituted for cortisol or cortisone so that the plasma 1 1-hydroxycorticoid levels during the test will be a measure of the patient's adrenocortical activity only. I usually give an intramuscular injection of 50 units of ACTH gel every twelve hours for three days and measure the plasma 11-hydroxycorticoid level five hours after each morning injection. Four patients withAddison's disease have shown no response to this test, whilst 6 patients with secondary adrenal atrophy have all shown a significant rise by the second day. Some people prefer to give ACTH by the intravenous route to ensure adequate adrenal stimulation, but the intramuscular route is more convenient andI have hadno difficulty in detecting a response in normal patients using ACTH gel in this dosage. Patients should be resting during this test, and care must be taken in obese patients to see that the injections are made into muscle and not into fat.
Adrenal Hypofunction

Cushing's Syndrome
Morning plasma 1 l-hydroxycorticoid levels have been measured in 26 patients with Cushing's syndrome. Only half these patients had levels which were consistently higher than the upper limit of the normal morning range. Nevertheless, plasma 1 1-hydroxycorticoid estimations can be very helpful in the diagnosis of Cushing's syndrome, particularly when the more orthodox urinary steroid estimations have given normal or equivocal results. This situation was present in the patient described below.
Case 2 E C, female, aged 49 This patient had been gaining weight for two years and had developed mild hirsutism. On examination she had a moon-face, generalized obesity, and a blood pressure of 160/100. Her fasting blood glucose level was normal but she had a diabetic glucose tolerance curve. Her urinary 17-oxogenic steroid excretion was normal but the morning plasma 1 1-hydroxycorticoid levels were consistently raised, the mean of four estimations being 38-2 ,ug/100 ml (Fig 2) . The plasma level fell during the oral administration of 0-5 g of Metopironel every four hours for twenty-four hours, and there was a moderate rise in the urinary steroid excretion on this day. During a dexamethasone suppression test, the morning plasma 1l-hydroxycorticoid level only fell to 23 ,ug/100 ml. A diagnosis of bilateral adrenal hyperplasia was made, and she went into remission following the implantation of radioactive seeds into her pituitary. The normal diurnal rhythm of the plasma 1 1-hydroxycorticoid level was absent in this patient and did not return after treatment.
It has been known for some years that the normal diurnal rhythm of the plasma cortisol level is often lost in Cushing's syndrome (Eik Ness et al. 1955) , and it has been absent or markedly reduced in most of the patients I have studied.
When investigating patients suspected of having Cushing's syndrome it is not enough only to confirm the presence of increased adrenocortical activity. The nature of the underlying condition, whether hyperplasia or tumour, is (Chappell 1963) .
Pituitary-adrenal Suppression
The pituitary-adrenal axis is rapidly suppressed in most patients receiving oral corticosteroid therapy, provided that they are not suffering from Cushing's syndrome. This fall in adrenocortical activity can be easily confirmed by measuring the morning plasma 11 -hydroxycorticoid level.
The mean morning level in 30 patients receiving prednisone or prednisolone acetate in a dose of 15 mg or more daily was only 3-2 ,g/100 ml. The mean morning level in 22 other patients receiving dexamethasone in a dose of 2 mg or more daily was only 2-7 ,ug/100 ml. None of these 52 patients had a morning level higher than 7 0 ,g/100 ml.
. 29 719 a--* I have now encountered 5 patients on sudpressive doses of corticosteroids who have had normal or high morning plasma 11-hydroxycorticoid levels. All had some disorder of the gastro-intestinal system at the time the blood was taken, and it is possible that malabsorption of the corticosteroids was responsible for the failure to suppress adrenocortical activity. This is of some importance clinically, for such patients may well respond to parenteral corticosteroids or to ACIH. Summary Plasma 1 1-hydroxycorticoid levels are a useful measure of adrenocortical activity and can be readily estimated by simple fluorimetric methods. These estimations can be used in the routine clinical investigation of adrenal function and are of particular value in the diagnosis of adrenal insufficiency.
Dr C L Cope (Postgraduate Medical School, London) said that the important advance was the simplicity and speed with which the plasma estimations could now be done. This fact had completely changed methods of handling adrenal and corticosteroid problems in the wards. The new method enabled a rapid answer to be obtained to many clinical problems of adrenal behaviour.
Dr Ivor H Mills (St Thomas's Hospital Medical School, London) presented a communication on The Effect of Angiotensin on Aldosterone which will form part of a paper to be published elsewhere.
